Skip to main
AVAH
AVAH logo

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 13%
Buy 38%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Holdings Inc. demonstrated a robust financial performance, with revenue in the Private Duty Services segment reaching $514.4 million, reflecting a remarkable 25.6% year-over-year growth, an outcome attributed to strong execution and the successful integration of the Thrive platform. The Home Health & Hospice segment also performed well, generating $62.4 million in revenue, a 15.3% increase from the previous year, driven by significant growth in total and episodic admissions. Overall, Aveanna’s financial flexibility appears to be improving, supported by a cash flow performance that exceeds expectations and an increased revenue guidance to over $2.375 billion, indicating a positive outlook for the company's future operations.

Bears say

Aveanna Healthcare Holdings Inc faces significant challenges that contribute to a negative outlook. Key concerns include potential reimbursement pressures, difficulties in sourcing and integrating acquisitions, and slower-than-anticipated organic growth, all exacerbated by high leverage and increasing competition in the home healthcare market. Additionally, the company is experiencing labor headwinds that are projected to adversely impact adjusted EBITDA, alongside a decline in gross margins, indicating potential vulnerabilities in its financial performance and operational efficiency.

AVAH has been analyzed by 8 analysts, with a consensus rating of Buy. 13% of analysts recommend a Strong Buy, 38% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 8 analysts, AVAH has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.19, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.19, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.